StockData
MeiraGTx Holdings plc logo

MeiraGTx Holdings plc (MGTX) stock

MGTXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 13/3065% below fair value
$8.32−0.14 (-1.65%)

Close on Nov 18, 2026Market cap $799.08MP/E 11.7Yield –

MeiraGTx market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

MeiraGTx's market cap was $911.74M on Nov 11, 2026, against $667.98M a year earlier. Over the last 5 years it ranged from $250.63M to $1.30B, with a median of $418.37M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$911.74M+42.5%
2025Dec 31, 2025$639.81M+35.2%
2024Dec 31, 2024$473.17M+13.1%
2023Dec 29, 2023$418.37M+43.5%
2022Dec 30, 2022$291.51M-72.3%
2021Dec 31, 2021$1.05B+80.9%
2020Dec 31, 2020$581.56M-20.6%
2019Dec 31, 2019$732.17M+179.4%
2018Dec 31, 2018$262.06M–

More MeiraGTx figures

See a number that looks wrong?